VPA was also shown to increase sensitivity of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and led to downregulation of c-FLIP (L) expression, despite of the fact that CLL cells are commonly resistant to death receptor-induced apoptosis [27]. The gene discussed is CFLAR; the disease is B-cell chronic lymphocytic leukemia.